Skip to main content
CLP 2023 Main banner
Final Program


CLP 2023 Program
Back

Samantha Meltzer-Brody, MD

Assad Meymandi Distinguished Professor and Chair, Department of Psychiatry
University of North Carolina School of Medicine
Chapel Hill, North Carolina

Dr. Samantha Meltzer-Brody, MD, MPH is the Assad Meymandi Distinguished Professor and Chair of the Department of Psychiatry at the University of North Carolina at Chapel Hill. She also directs the UNC Center for Women’s Mood Disorders. As Chair, Dr. Meltzer-Brody directs one of the largest public university departments of psychiatry in the United States and is a passionate advocate for innovation and transformation of mental health care.

Dr. Meltzer-Brody is an internationally recognized physician-scientist. Her research investigates the epidemiologic and biological predictors of perinatal depression and innovative treatment approaches (pharmacologic and psychotherapeutic), which have taken her across the globe. She had led the MOMS GENES study—the largest global genetic study of postpartum depression (PPD) using app based tools. She also served as the academic PI for the novel psychopharmacologic clinical trials developing the first FDA approved medication for postpartum depression (brexanolone) and also served an investigator for the newly approved oral drug (zuranolone) for PPD.

Dr. Meltzer-Brody has received numerous awards. She received the 2023 NIH Clinical Center Distinguished Clinical Research Scholar and Educator in Residence, and the 2020 UNC O Max Gardner award, a UNC System Award (17 universities) for the highest faculty honor. Dr. Meltzer-Brody is also the recipient of the 2019 American Psychiatric Association Alexandra Symonds Award in Women’s Mental Health. She was named to the 2022, Forbes list of 16 Healthcare Innovators You Should Know and was ranked in 2021 by Expertscape, as the number one expert in the world for postpartum depression.

Presentation(s):

Email Samantha